Immuron (IMRN) Receivables - Other (2016 - 2025)

Immuron (IMRN) posted quarterly Receivables - Other of $23688.0 for Q3 2025, up 41.6% on a QoQ basis from $16729.1 in Q2 2025.

Immuron (IMRN) Receivables - Other (2016 - 2025) Analysis & Trends

Immuron (IMRN) has reported Receivables - Other for 5 consecutive years, with $23688.0 the latest figure, recorded in Q3 2025.

  • Quarterly Receivables - Other changed N/A year-over-year to $23688.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $23688.0 (changed N/A YoY) and the FY2025 annual result came in at $23688.0, changed N/A from the prior year.
  • Receivables - Other grew to $23688.0 in Q3 2025 per IMRN's latest filing, from $16729.1 in the prior quarter.
  • Over the last five years, Receivables - Other for IMRN reached as high as $1.1 million in Q2 2023 and fell as low as $16729.1 in Q2 2025.
  • A 3-year average of $244371.5 and a median of $22939.6 in 2024 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2024 — Receivables - Other plunged 98.26% — and 2025, when it fell 15.4%.
  • Year by year, Receivables - Other stood at $1.1 million in 2023, then slumped by 97.99% to $22939.6 in 2024, then advanced by 3.26% to $23688.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $23688.0, $16729.1, and $22939.6 for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immuron 270.20 Mn 258.54 Mn -

Historic Data

Download Data
DateValue
Sep 2, 2025 23,688.00
Sep 2, 2025 23,688.00
Jun 30, 2025 16,729.05
Jun 30, 2025 16,729.05
Dec 31, 2024 22,939.59
Dec 31, 2024 22,939.59
Jun 30, 2024 19,774.29
Jun 30, 2024 19,774.29
Jun 30, 2023 1.14 Mn
Jun 30, 2023 1.14 Mn
Jun 30, 2019 97,580.48
Jun 30, 2019 97,580.48
Jun 30, 2016 1.84 Mn
Jun 30, 2016 1.84 Mn